Is Your Cosmetic Surgery Center Ready to Sell?

Most states prohibit non-physicians from owning a medical practice under corporate practice of medicine (CPOM) laws. A properly structured Management Services Organization (MSO) separates the business entity — which can be sold to a non-physician buyer — from the professional corporation (PC) that employs physicians and bills for medical services. If your practice is not already structured this way, engage a healthcare attorney immediately. Buyers will not close without a CPOM-compliant structure, and retrofitting this post-LOI is expensive and time-consuming.

Cosmetic surgery practice transactions require advisors who understand fee-splitting laws, MSO structuring, physician employment agreements, and SBA lender requirements for healthcare deals. A generalist business broker unfamiliar with CPOM or malpractice tail coverage obligations can inadvertently expose you to liability or allow you to accept a poorly structured LOI that collapses in due diligence. Engage a specialist early — before you receive any offer — so you negotiate from a position of knowledge.

Buyers and SBA lenders require at least three years of clean financial statements — either CPA-reviewed or audited — with a clear separation between personal expenses and legitimate business costs. Common issues in cosmetic surgery practices include personal auto expenses, personal travel, and family member compensation running through the business. Work with your CPA to normalize these add-backs into a formal Seller's Discretionary Earnings (SDE) or EBITDA schedule that will hold up to buyer scrutiny and lender underwriting.

Compile and verify the current status of all physician licenses, DEA registrations, state controlled substance permits, facility operating licenses, and any accreditation (AAAHC or Joint Commission) your surgical suite holds. Confirm that each credential is transferable or re-issuable to a new owner or management entity. Lapses or pending renewals discovered during due diligence are major red flags that can delay or kill a deal. If your facility is not yet accredited, beginning the AAAHC process now adds measurable enterprise value.

Request a complete claims history from your malpractice carrier covering the past five to ten years. Review every claim, complaint, settlement, and board action — including any that were dropped or settled without admission of liability. Buyers will obtain this independently, so there should be no surprises. If there are open claims, engage healthcare legal counsel to assess resolution timelines. Understand your tail coverage obligations if you are on a claims-made policy, and factor the tail premium into your deal economics.

If 80% or more of your surgical revenue is personally generated by you as the selling physician, most sophisticated buyers will discount your valuation significantly or require an extended and financially punitive earnout. The single most impactful thing you can do to increase enterprise value is to hire an associate surgeon or experienced nurse practitioner who can perform surgical consults and, ideally, assist or lead lower-complexity cases. Even a partial shift of surgical revenue attribution from you to an associate materially reduces key-man concentration.

Non-surgical procedures — Botox, dermal fillers, laser resurfacing, body contouring — are the most transferable and buyer-valued revenue in a cosmetic surgery center because they are performed by nurses and aestheticians rather than the selling surgeon. Document your non-surgical revenue as a percentage of total revenue, your patient retention rates for repeat treatments, and average revenue per non-surgical patient per year. If non-surgical revenue is below 30% of total revenue, consider investing in marketing and additional injectable staff to grow this line before going to market.

Prepare a detailed summary of your active patient database, including total active patients (seen in the last 24 months), average visits per patient per year, average revenue per patient, and procedure mix breakdown. This data must be presented in anonymized, de-identified format to comply with HIPAA during the pre-LOI marketing process. A well-documented, growing patient database is one of the most compelling proof points that revenue will survive your departure and is a primary underwriting input for both buyers and SBA lenders.

Buyers of cosmetic surgery centers are acutely aware that skilled injectors — registered nurses, nurse practitioners, and physician assistants performing Botox and filler treatments — often have their own patient followings. If your top revenue-generating non-physician staff are at-will employees with no non-solicitation or non-compete agreements, a buyer faces the risk of losing that revenue the day they close. Work with a healthcare employment attorney to put appropriate non-solicitation agreements in place now, in a legally enforceable manner for your state.

If more than 60% of your surgical revenue comes from one procedure type (e.g., breast augmentation) or one referral channel (e.g., one plastic surgery referral partner), buyers will discount for concentration risk. Review your procedure mix across the past three years and identify any meaningful diversification opportunities — whether through adding services, training associate staff, or broadening your marketing channels — that can be documented before going to market.

Buyers acquiring a cosmetic surgery center are not just buying revenue — they are buying a replicable business system. Document your EMR platform (Nextech, Modernizing Medicine, PatientNow, or similar), your patient intake and consent workflows, your pre- and post-operative care protocols, your marketing and lead management processes, and your financial reporting cadence. Practices with documented systems signal to buyers that the business can operate and grow without the founder's daily presence, which is a core driver of enterprise value above 4.5x EBITDA.

Compile every physician employment agreement, staff employment contract, independent contractor agreement, equipment lease, facility lease, and vendor service agreement. Review each for assignment provisions — many contracts require consent from the other party before they can be transferred to a new owner. Negotiate assignment rights proactively where they are missing. Ensure physician non-compete and non-solicitation agreements are appropriately scoped, particularly for any associate physicians whose continued employment will be a closing condition.

Write a detailed, documented plan for how you will introduce the incoming physician or management team to your patients, how existing pre-surgical and post-surgical care will be managed through the transition, and how key referral relationships (primary care physicians, dermatologists, other surgeons) will be handed off. Buyers and their lenders will want to see this plan before closing, and many will tie a portion of earnout payments to demonstrable patient retention metrics in the 12 months post-close.

Conduct a full audit of all major equipment — laser platforms, body contouring devices, surgical equipment, imaging systems — including age, lease versus owned status, maintenance history, and estimated replacement timelines. Buyers will perform this audit during due diligence, and deferred capital expenditures will be used as negotiating leverage to reduce the purchase price. Proactively addressing or disclosing near-term capex needs, and obtaining current fair market valuations for owned equipment, positions you to defend your asking price.

Review your HIPAA Privacy and Security policies, your Business Associate Agreements with all vendors and service providers, your employee training records, and your breach notification procedures. Buyers conducting due diligence on a medical practice will review HIPAA compliance as a standard step, and gaps signal broader operational risk. If you have not had a formal HIPAA risk assessment in the past two years, engage a healthcare compliance consultant to conduct one and document the findings and any remediation steps taken.

Work with your M&A advisor to prepare a professional Confidential Information Memorandum that presents your practice's financial performance, patient demographics, procedure mix, staff structure, facility details, growth opportunities, and CPOM compliance structure in a format designed for sophisticated healthcare acquirers. A CIM for a cosmetic surgery center must address corporate structure, malpractice history, and key-man metrics explicitly — not bury them. Sophisticated buyers will find these issues in due diligence regardless, and proactive disclosure builds trust and deal momentum.

Many lower middle market cosmetic surgery practice acquisitions are financed with SBA 7(a) loans, which require the business to meet specific eligibility criteria including a clean operational history, personal financial statement review of the buyer, and lender approval of the practice's cash flow coverage ratios. As a seller, understanding what SBA lenders will require — including the likelihood of a seller note covering 10–20% of the deal — allows you to price your deal and structure your terms to match the most realistic buyer financing scenario, avoiding deals that fall apart at the lender underwriting stage.

Avoid the temptation to accept the first offer you receive, particularly from a strategic acquirer or PE platform who approaches you directly. A controlled competitive process — even with just three to five qualified buyers — consistently produces higher valuations and better deal terms than a bilateral negotiation. Your M&A advisor should be managing buyer outreach, NDA execution, CIM distribution, and management presentation scheduling in a way that creates time pressure and negotiating leverage while preserving complete confidentiality from your staff and patients.

Most cosmetic surgery center acquisitions will include some form of earnout (typically 10–20% of deal value tied to 12–24 months of post-close revenue retention) and potentially a request for seller rollover equity (10–20% of deal value re-invested in the acquiring entity). Understand the tradeoffs: earnouts protect the buyer against revenue loss post-transition, but they expose you to payout risk if patient volumes dip for reasons outside your control. Negotiate earnout metrics that are based on clinic revenue — not your personal production — and ensure rollover equity terms include a defined liquidity path.